Phospshoinositide 3-Kinase (PI3K)/Mammalian Target of Rapamycin (mTOR) Dual Inhibitors: Discovery and Structure–Activity Relationships of a Series of Quinoline and Quinoxaline Derivatives
Nobuko Nishimura(Amgen (United States)), Mark H. Norman(Amgen (United States)), Raju Subramanian(Gilead Sciences (United States)), Nancy R. Zhang(University of the Arts), Kevin Yang(Revolution Medicines (United States)), Leeanne Zalameda(Amgen (United States)), Tisha San Miguel(Amgen (United States)), Douglas A. Whittington(Amgen (United States)), Erin L. Mullady(Amgen (United States)), Marian C. Bryan(Johnson & Johnson (United States)), Shon K. Booker(Amgen (United States)), Longbin Liu(National University of Defense Technology), Ling Wang(Amgen (United States)), Hongyu Liao, Paul E. Hughes(Amgen (United States)), Sean Caenepeel(Amgen (United States)), Kristin L. Andrews(Amgen (United States)), Aaron Siegmund(Amgen (United States)), Yunxin Bo(Amgen (United States)), John D. McCarter(Amgen (United States)), Daniel J. Freeman(Amgen (United States)), Nuria Tamayo(Amgen (United States))
Cited by 60
Related Papers
Key Green Chemistry research areas from a pharmaceutical manufacturers’ perspective revisited
|Green Chemistry|2018|598
Integrin activation controls metastasis in human breast cancer
|Proceedings of the National Academy of Sciences|2001|580
Glucuronidation of Statins in Animals and Humans: A Novel Mechanism of Statin Lactonization
|Drug Metabolism and Disposition|2002|346
Probing the dynamics of O-GlcNAc glycosylation in the brain using quantitative proteomics
|Nature Chemical Biology|2007|330
Effects of Fibrates on Metabolism of Statins in Human Hepatocytes
|Drug Metabolism and Disposition|2002|325